# Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

> **NCT00226499** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 5803 (actual)

## Conditions studied

- Varicella
- Chickenpox Vaccines

## Interventions

- **BIOLOGICAL:** Priorix-tetra™
- **BIOLOGICAL:** Priorix™
- **BIOLOGICAL:** Varilrix™

## Key facts

- **NCT ID:** NCT00226499
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-01
- **Primary completion:** 2006-10-12
- **Final completion:** 2006-10-12
- **Target enrollment:** 5803 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226499, "Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00226499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*